Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

NCT01783535 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Retinoblastoma

Interventions

DRUG: vincristine
DRUG: topotecan
DRUG: filgrastim
DRUG: PEG-filgrastim
DRUG: carboplatin
OTHER: focal therapy
DRUG: etoposide
DRUG: cyclophosphamide
DRUG: MESNA
DRUG: doxorubicin
PROCEDURE: enucleation
RADIATION: external beam radiation or proton beam radiation

Sponsor

St. Jude Children's Research Hospital